{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:54:24Z","timestamp":1782921264214,"version":"3.54.5"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review and network meta-analysis compared the long-term effects of endovascular reconstruction\/revascularization (ER), supervised exercise therapy (SET), medical therapy (MT), and their combined regimens on cardiovascular and cerebrovascular events, all-cause mortality, and limb outcomes in patients with peripheral artery disease (PAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Chinese and English databases were searched from inception to April 8, 2026 for randomized controlled trials (RCTs) comparing ER, SET, MT, or their combinations in adults with PAD. The protocol was registered prospectively in PROSPERO (CRD420261362458). Risk of bias was assessed using the Cochrane RoB 2.0 tool. A frequentist network meta-analysis was performed in Stata 19.0. Odds ratios (ORs) were used for binary outcomes and mean differences (MDs) for continuous outcomes. Treatment ranking was summarized using the surface under the cumulative ranking curve (SUCRA), network consistency was evaluated by node-splitting, and certainty of evidence was assessed using the CINeMA framework.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen RCTs including 1,461 participants were eligible. For all-cause mortality, ER + SET + MT had the highest SUCRA value (99.4%), suggesting the greatest probability of benefit within the available evidence network. For cardiovascular events and cerebral infarction, ER + MT ranked highest, with SUCRA values of 76.7 and 85.3%, respectively. For amputation, SET + MT showed the highest SUCRA value (77.7%), indicating a greater probability of limb-salvage benefit. For ABI improvement, ER + SET + MT ranked highest (85.2%). Subgroup analyses suggested that the apparent amputation-protective effect of ER combined with ordinary medical therapy (ER + OMT) was larger than that of ER combined with best medical therapy (ER + BMT), although the direction of effect was consistent. Sensitivity analyses did not materially change the main rankings. Overall certainty of evidence was mainly moderate to low, largely because of clinical heterogeneity, sparse direct comparisons, limited reporting quality in some trials, and possible publication bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In patients with PAD, ER + SET + MT may offer a favorable ranking profile for all-cause mortality and limb perfusion, ER + MT appears to rank favorably for cardiovascular and cerebrovascular events, and SET + MT may be particularly relevant for amputation prevention. These rankings should be interpreted cautiously because SUCRA values indicate relative ranking probability rather than definitive clinical superiority, and several comparisons were supported by limited direct evidence, heterogeneous populations, and moderate-to-low certainty. Further large, long-term, head-to-head RCTs are needed to confirm the optimal integrated treatment strategy for different PAD phenotypes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1874951","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:41:36Z","timestamp":1782920496000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of endovascular revascularization, pharmacotherapy, and supervised exercise therapy on long-term cardiovascular, cerebrovascular, mortality, and limb outcomes in patients with peripheral artery disease: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiayue","family":"Feng","sequence":"first","affiliation":[{"name":"Department of Peripheral Vascular Surgery, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital","place":["Beijing, China"]},{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang","family":"Ju","sequence":"additional","affiliation":[{"name":"Department of Peripheral Vascular Surgery, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Peripheral Vascular Surgery, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital","place":["Beijing, China"]},{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1056\/NEJMcp2501200","article-title":"Peripheral artery disease in the legs.","volume":"394","author":"McDermott","year":"2026","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"crossref","first-page":"e1553","DOI":"10.1016\/S2214-109X(23)00355-8","article-title":"Global burden of peripheral artery disease and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"11","year":"2023","journal-title":"Lancet Glob Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC guidelines for the management of peripheral arterial and aortic diseases.","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e000135","DOI":"10.1161\/HCQ.0000000000000135","article-title":"Understanding the pain experience and treatment considerations along the spectrum of peripheral artery disease: a scientific statement from the American Heart Association.","volume":"18","author":"Smolderen","year":"2025","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e15655","DOI":"10.7759\/cureus.15655","article-title":"Peripheral artery disease as a risk factor for myocardial infarction.","volume":"13","author":"P\u00e9rez Mejias","year":"2021","journal-title":"Cureus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1161\/STROKEAHA.118.023534","article-title":"Stroke in patients with peripheral artery disease.","volume":"50","author":"Kolls","year":"2019","journal-title":"Stroke."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e006550","DOI":"10.1161\/CIRCOUTCOMES.120.006550","article-title":"Cause of death among patients with peripheral artery disease: insights from the EUCLID trial.","volume":"13","author":"Kochar","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B8","doi-asserted-by":"publisher","first-page":"102430","DOI":"10.1016\/j.cpcardiol.2024.102430","article-title":"Pharmacotherapy and revascularization strategies of peripheral artery disease.","volume":"49","author":"Moras","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association.","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e700","DOI":"10.1161\/CIR.0000000000000727","article-title":"Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association.","volume":"140","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e012541","DOI":"10.1161\/JAHA.119.012541","article-title":"Adherence to guideline-recommended therapy-including supervised exercise therapy referral-across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry.","volume":"9","author":"Saxon","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejvs.2023.10.013","article-title":"The new ESVS practice guidelines for intermittent claudication are exactly what we need.","volume":"67","author":"Hicks","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia.","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"B16","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024).","author":"Higgins","year":"2024"},{"key":"B17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis.","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"B19","first-page":"31","article-title":"Efficacy of vascular stent intervention for lower extremity arteriosclerosis obliterans.","volume":"15","author":"Kong","year":"2014","journal-title":"Pract Clin Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ejvs.2023.01.004","article-title":"Long term results of a randomised trial of stenting of the superficial femoral artery for intermittent claudication.","volume":"65","author":"Gunnarsson","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/bjs.9207","article-title":"Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial.","volume":"100","author":"Fakhry","year":"2013","journal-title":"Br J Surg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejvs.2021.09.042","article-title":"Editor\u2019s choice - randomised clinical trial of supervised exercise therapy vs. endovascular revascularisation for intermittent claudication caused by iliac artery obstruction: the SUPER study.","volume":"63","author":"Koelemay","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e1035","DOI":"10.1097\/SLA.0000000000004712","article-title":"Long-term follow-up of a randomized clinical trial comparing endovascular revascularization plus supervised exercise with supervised exercise only for intermittent claudication.","volume":"276","author":"Klaphake","year":"2022","journal-title":"Ann Surg"},{"key":"B24","first-page":"10","article-title":"Effect of percutaneous transluminal angioplasty combined with vascular stent for lower extremity arteriosclerosis obliterans.","volume":"16","author":"Zhang","year":"2018","journal-title":"China Foreign Med Res."},{"key":"B25","first-page":"55","article-title":"Interventional therapy and clinical application evaluation of lower extremity arteriosclerosis obliterans.","volume":"16","author":"Zhang","year":"2018","journal-title":"Guide China Med."},{"key":"B26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13020-022-00632-5","article-title":"Clinical efficacy of iliofemoral artery stent implantation in treatment of lower extremity atherosclerotic occlusive disease.","volume":"20","author":"Liu","year":"2022","journal-title":"Guide China Med."},{"key":"B27","first-page":"384","article-title":"Observation on the therapeutic effects of interventional treatment and simple conservative treatment for lower extremity arteriosclerosis obliterans.","volume":"39","author":"Weiming","year":"2015","journal-title":"Heilongjiang Med."},{"key":"B28","first-page":"68","article-title":"Analysis of the therapeutic effect of interventional treatment for lower extremity arteriosclerotic occlusive disease.","volume":"36","author":"Huiliang","year":"2017","journal-title":"Chin Foreign Med J."},{"key":"B29","first-page":"147","article-title":"Analysis of the therapeutic effect of interventional treatment for lower limb arteriosclerosis occlusion.","volume":"17","author":"Longhu","year":"2017","journal-title":"World Late Med Informat Abst."},{"key":"B30","first-page":"27","article-title":"Analysis of the interventional treatment effect of lower limb arteriosclerosis occlusion.","volume":"5","author":"Dong","year":"2017","journal-title":"Cardiovasc Dis J Integr Tradit Chin West Med."},{"key":"B31","first-page":"124","article-title":"Clinical observation of PTA combined with endovascular stent in treatment of lower extremity arteriosclerosis obliterans.","volume":"32","author":"Jiao","year":"2019","journal-title":"Acta Med Sin."},{"key":"B32","first-page":"95","article-title":"Traumatic study of PTA and endovascular stent for lower extremity arteriosclerosis obliterans.","volume":"25","author":"Wu","year":"2020","journal-title":"Zhejiang J Trauma Surg."},{"key":"B33","first-page":"46","article-title":"Analysis of interventional therapy for lower extremity arteriosclerosis obliterans.","volume":"24","author":"Dong","year":"2015","journal-title":"Henan Med Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e019672","DOI":"10.1161\/JAHA.120.019672","article-title":"Network meta-analysis comparing the outcomes of treatments for intermittent claudication tested in randomized controlled trials.","volume":"10","author":"Thanigaimani","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jcin.2019.02.018","article-title":"Supervised exercise therapy and revascularization for intermittent claudication: network meta-analysis of randomized controlled trials.","volume":"12","author":"Saratzis","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"B36","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.jcin.2017.01.027","article-title":"Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials.","volume":"10","author":"Pandey","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"B37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.ejvs.2018.12.023","article-title":"The effect of supervised exercise, home based exercise and endovascular revascularisation on physical activity in patients with intermittent claudication: a network meta-analysis.","volume":"58","author":"van den Houten","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B38","doi-asserted-by":"publisher","first-page":"CD005263","DOI":"10.1002\/14651858.CD005263.pub4","article-title":"Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.","volume":"4","author":"Hageman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/SLA.0000000000005793","article-title":"Long-term outcomes of exercise therapy versus revascularization in patients with intermittent claudication.","volume":"278","author":"Shirasu","year":"2023","journal-title":"Ann Surg"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e024279","DOI":"10.1161\/JAHA.121.024279","article-title":"Cardiovascular and limb events following endovascular revascularization among patients =65 years old: an American College of Cardiology PVI registry analysis.","volume":"11","author":"Weissler","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s choice \u2013 European society for vascular surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication.","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1874951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:41:39Z","timestamp":1782920499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1874951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":41,"alternative-id":["10.3389\/fmed.2026.1874951"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1874951","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"article-number":"1874951"}}